Orion Infusion Ltd.
328.40
BDT
-3.50
-1.05%
Last updated on 16 Apr, 14:01
Today
-1.05%
1 Week
-3.27%
1 Month
-8.73%
6 Month
-33.33%
1 Year
-15.30%
5 Year
355.48%
Matket Today
Open
333.8
BDT
Low
327.5
BDT
High
335.9
BDT
Volume
206741
Value
6.83
Crore
Trade
3008
YCP
331.9
BDT
52W Low
303.3
BDT
52W High
587.5
BDT
Circuit Low
302.9
BDT
Circuit Up
360.9
BDT
Beta (1 Year)
0.95
Financial Indicators
P/E ratio
142.78
EPS (TTM)
2.30
NAV (Q2 2026)
15.90
Total Shares
2.04
Crore
Shot-term loan
30.57
Crore
Long-term loan
0
Crore
Market Capital
675.74
Crore
Paid-up Capital
20.36
Crore
Authorized Capital
100
Crore
AGM Date
-
Record Date
-
Year End
30-Jun
About Orion Infusion Ltd.
Orion Infusion Ltd, formerly known as Mala Chemical & Pharmaceuticals Industries Ltd, commenced its operations in 1989 and transitioned into a public limited company in 1994. The company specializes in the production of Large Volume Parenteral (LVP) and other life-saving injectable products, establishing itself as a prominent Large Volume I.V. manufacturer in Bangladesh. Orion Infusion Ltd's manufacturing facilities are dedicated to producing a range of medical solutions, including I.V. Rehydration Solutions, Electrolyte Solutions, Solution for Acidosis, Ranitidine I.V. infusion, and various Anti-Microbial products such as Ciprofloxacin I.V. and Metronidazole I.V. To meet growing demand, the company is expanding its production capacity, incorporating modern technologies to enhance core competency. Notably, Orion Infusion Ltd has shifted to producing pure steam-generated fluids to comply with cGMP requirements. Innovation is a key focus, with the introduction of groundbreaking products like Amino acids solution, marking the first-ever manufacturing of this product in Bangladesh and providing the company a competitive advantage. The company's commitment to quality is outlined in its Quality Manual, emphasizing quality policies and a company-wide control structure within the quality management system (QMS) to align with its corporate vision and mission.

